The US Food and Drug Administration (FDA) has granted Axiostat Gauze, a line of advanced hemostatic gauze that stops severe traumatic bleeding, 510(k) clearance, according to Axio Biosolutions, a pioneer in cutting-edge advanced woundcare products. Z-fold axiostat Hemostatic gauze, which is used by many military services
In a race against time, Axio Biosolutions, a leading Indian medical device manufacturer, came to the aid of the Border Security Force (BSF) unit deployed in Northeast India. The BSF team urgently required Axio's revolutionary haemostatic product, Axiostat, to address a critical situation. Despite the
Axio Biosolutions, a biomaterial focused medtech company today announced the US Food and Drug Administration (FDA) 510(k) clearance for its latest innovation, Ax-Surgi Surgical Hemostat. With this, Ax-surgi has become the first and only chitosan-based hemostat cleared for controlling severe surgical bleeding. Ax-Surgi is based on
Axio Biosolutions, a biomaterial focused medtech company today announced the US Food and Drug Administration (FDA) 510(k) clearance for its latest innovation, Ax-Surgi Surgical Hemostat. With this, Ax-surgi has become the first and only chitosan-based hemostat cleared for controlling severe surgical bleeding. Ax-Surgi is based on
